Current issues in Antibiotic Use - Internal Medicine | ACP

CRE = Enterobacteriaceae resistant to one of the carbepenems (Doripenem, imipenem or meropenem) and third generation cephalosporins (ceftriaxone, cefotaxime, ceftazidime) Guidance for Control of Carbapenem-resistant Enterobacteriaceae - 2012 CRE Toolkit, CDC. Antibiotic Resistance Threats in the U.S., 2013. CDC

Author:
Uploaded by: Murkka Svensdottir
Filesize: 4 MB